Literature DB >> 20871216

Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.

Haipeng Shao1, Liqiang Xi, Mark Raffeld, Stefania Pittaluga, Kieron Dunleavy, Wyndham H Wilson, Nelson Spector, Cristiane Milito, Jose Carlos Morais, Elaine S Jaffe.   

Abstract

Plasmacytomas expressing immunoglobulin A are rare and not well characterized. In this study, 9 cases of IgA-positive plasmacytoma presenting in lymph node and 3 in extranodal sites were analyzed by morphology, immunohistochemistry, and polymerase chain reaction examination of immunoglobulin heavy and κ light chain genes. Laboratory features were correlated with clinical findings. There were 7 males and 5 females; age range was 10 to 66 years (median, 32 y). Six of the patients were younger than 30 years of age, 5 of whom had nodal disease. About 67% (6 of 9) of the patients with nodal disease had evidence of immune system dysfunction, including human immunodeficiency virus infection, T-cell deficiency, autoantibodies, arthritis, Sjögren syndrome, and decreased B cells. An IgA M-spike was detected in 6 of 11 cases, and the M-protein was nearly always less than 30 g/L. All patients had an indolent clinical course without progression to plasma cell myeloma. Histologically, nodal IgA plasmacytomas showed an interfollicular or diffuse pattern of plasma cell infiltration. The plasma cells were generally of mature Marschalko type with little or mild pleomorphism and exclusive expression of monotypic IgA. There was an equal expression of κ and λ light chains (ratio 6:6). Clonality was showed in 9 of 12 cases: by polymerase chain reaction in 7 cases, by cytogenetic analysis in 1 case, and by immunofixation in 1 case. Clonality did not correlate with pattern of lymph node infiltration. Our results suggest that IgA plasmacytomas may represent a distinct form of extramedullary plasmacytoma characterized by younger age at presentation, frequent lymph node involvement, and low risk of progression to plasma cell myeloma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20871216      PMCID: PMC2947321          DOI: 10.1097/PAS.0b013e3181f17d0d

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  46 in total

1.  Validation of immunoglobulin gene rearrangement detection by PCR using commercially available BIOMED-2 primers.

Authors:  R F McClure; P Kaur; E Pagel; P D Ouillette; C E Holtegaard; C L Treptow; P J Kurtin
Journal:  Leukemia       Date:  2006-01       Impact factor: 11.528

2.  Hashimoto's thyroiditis manifesting monoclonal lymphocytic infiltration.

Authors:  S Matsubayashi; H Tamai; T Morita; S Fukata; F Matsuzuka; T Suzuki; K Kuma; S Nagataki; R Volpé
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

3.  Multicentric Castleman's disease in association with a solitary plasmacytoma: a case report.

Authors:  S J Gould; T Diss; P G Isaacson
Journal:  Histopathology       Date:  1990-08       Impact factor: 5.087

4.  Primary plasmacytoma of generalized lymph nodes: a long survivor.

Authors:  T Matsushima; H Murakami; J Tamura; M Sawamura; T Naruse; J Tsuchiya
Journal:  Am J Hematol       Date:  1993-07       Impact factor: 10.047

5.  TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo.

Authors:  B B Cazac; J Roes
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

6.  Primary pulmonary plasmacytoma involving bilateral lungs and marked hypergammaglobulinemia: differentiation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.

Authors:  Nozomi Niitsu; Mika Kohri; Miyuki Hayama; Hirokazu Nakamine; Naoya Nakamura; Masami Bessho; Masaaki Higashihara
Journal:  Leuk Res       Date:  2005-11       Impact factor: 3.156

7.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

8.  Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms.

Authors:  I Ramasamy; M Brisco; A Morley
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

Review 9.  Multiple myeloma and systemic lupus erythematosus in a young woman.

Authors:  Kelechi Okoli; Farzan Irani; William Horvath
Journal:  J Clin Rheumatol       Date:  2009-09       Impact factor: 3.517

10.  Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

Authors:  T Defrance; B Vanbervliet; F Brière; I Durand; F Rousset; J Banchereau
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

View more
  13 in total

1.  Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.

Authors:  Joo Y Song; Franziska C Eberle; Liqiang Xi; Mark Raffeld; Osama Rahma; Wyndham H Wilson; Kieron Dunleavy; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

2.  Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Authors:  Falko Fend; José Cabecadas; Philippe Gaulard; Elaine S Jaffe; Philip Kluin; Isinsu Kuzu; Loann Peterson; Andrew Wotherspoon; Christer Sundström
Journal:  J Hematop       Date:  2012-09       Impact factor: 0.196

3.  Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans.

Authors:  Hye Sun Kuehn; Julie E Niemela; Andreia Rangel-Santos; Mingchang Zhang; Stefania Pittaluga; Jennifer L Stoddard; Ashleigh A Hussey; Moses O Evbuomwan; Debra A Long Priel; Douglas B Kuhns; C Lucy Park; Thomas A Fleisher; Gulbu Uzel; João B Oliveira
Journal:  Blood       Date:  2013-02-21       Impact factor: 22.113

4.  Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.

Authors:  Franziska C Eberle; Joo Y Song; Liqiang Xi; Mark Raffeld; Nancy Lee Harris; Wyndham H Wilson; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

5.  Synchronous indolent primary gastrointestinal lymphomas managed successfully with conservative measures.

Authors:  Andrew S Brohl; Joo Y Song; Ron Lieberman; Barry Gause
Journal:  Am J Ther       Date:  2013 Sep-Oct       Impact factor: 2.688

6.  Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma.

Authors:  Qingyan Liu; Itziar Salaverria; Stefania Pittaluga; Armin G Jegalian; Liqiang Xi; Reiner Siebert; Mark Raffeld; Stephen M Hewitt; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

Review 7.  [B-cell neoplasms with plasmacellular and plasmablastic differentiation].

Authors:  F Fend; L Quintanilla-Martínez
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

8.  Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic Pitfall.

Authors:  Caoimhe Egan; Camille Laurent; Julie C Alejo; Stefano Pileri; Elias Campo; Steven H Swerdlow; Miguel Piris; Wing C Chan; Roger Warnke; Randy D Gascoyne; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2020-05       Impact factor: 6.298

9.  Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features.

Authors:  Ifeyinwa Emmanuela Obiorah; Ivo M B Francischetti; Hao-Wei Wang; Inhye E Ahn; Weixin Wang; Mark Raffeld; Robert J Kreitman; Adrian Wiestner; Katherine R Calvo
Journal:  Leuk Lymphoma       Date:  2020-08-05

10.  Primary submucosal nodular plasmacytoma of the stomach: a poorly recognized variant of gastric lymphoma.

Authors:  Maki Kanzawa; Chihoko Hirai; Yukiko Morinaga; Fumi Kawakami; Shigeo Hara; Hiroshi Matsuoka; Tomoo Itoh
Journal:  Diagn Pathol       Date:  2013-02-20       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.